Generic selectors Exact matches only Search in title Search in content Post Type Selectors Personalized Support For Your PROVENGE ® Patients Is Just A Call Away…
PROVENGE ® (sipuleucel-T) is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone-refractory) prostate cancer.
Acute Infusion Reactions: Acute infusion reactions (reported within 1 day of infusion) may occur and include nausea, vomiting, fatigue, fever, rigor or chills, respiratory events (dyspnea, hypoxia, and bronchospasm), syncope, hypotension, hypertension, and tachycardia.
Links to dendreononcall.com (6)
provengehcp.comPROVENGE® (sipuleucel-T) for Healthcare Providers
dendreonmedicalaffairs.comClinical & Safety Information on PROVENGE® (sipuleucel-T) mCRPC | Dendreon Medical Affairs
provengesupport.comPROVENGE Support for Practices and Patients | DendreonOnCall.com
prostatecancertrial.comClinical & Safety Information on PROVENGE® (sipuleucel-T) mCRPC | Dendreon Medical Affairs